Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases

被引:11
作者
Borgia, MC [1 ]
Mandolini, C
Barresi, C
Battisti, G
Carletti, F
Capobianchi, MR
机构
[1] Univ Roma La Sapienza, Dept Clin Sci, Rome, Italy
[2] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[3] Univ Roma La Sapienza, Surg Unit 3, Rome, Italy
[4] IRCCS, Natl Inst Infect Dis L Spallazani, Inst Virol, Rome, Italy
关键词
cytomegalovirus; anti-cytomegalovirus antibodies; cardiovascular diseases; interleukin-8;
D O I
10.1016/S0021-9150(00)00744-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The possible contribution of cytomegalovirus (CMV) to pathogenetic events associated with atherosclerotic lesion establishment and progression is still controversial. We evaluated the possibility that active ongoing CMV infection could be correlated to evolution of unstable atheromatous lesion, by analyzing patients suffering from unstable angina (n = 61). acute myocardial infarction (n = 43), stable angina (n = 26) and peripheral arteriopathy (n = 22) as compared to healthy subjects (n = 30). Particularly, we assessed: past exposure to CMV by evaluating anti-CMV IgG antibodies; ongoing CMV infection by evaluating anti-CMV IgM antibodies and circulating interleukin (IL)-8 in serum; and CMV DNAemia in peripheral blood mononuclear cells (PBMC). Mean IgG values were significantly increased in patients from all groups, as compared to healthy subjects. CMV-specific IgM, as well as CMV DNAemia, were undetectable in both controls and patients. Circulating IL-8, significantly elevated in a group of individuals experiencing active CMV infection, was not significantly higher in cardiovascular disease patients, as compared to control subjects. These findings confirm previous evidence from the increased exposure to CMV infection in patients with atheromatous lesions. However, they provide further evidence against a direct implication of active systemic CMV infection in the pathogenesis of cardiovascular diseases, particularly those involving plaque instability. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 41 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]  
BRUGGEMAN CA, 1991, PROG MED VIROL, V38, P1
[3]   Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: Possible role of endogenous interleukin-8 [J].
Capobianchi, MR ;
Barresi, C ;
Borghi, P ;
Gessani, S ;
Fantuzzi, L ;
Ameglio, F ;
Belardelli, F ;
Papadia, S ;
Dianzani, F .
JOURNAL OF VIROLOGY, 1997, 71 (02) :1591-1597
[4]   ROLE OF CALCIUM IN GAMMA INTERFERON INDUCTION - INHIBITION BY CALCIUM ENTRY BLOCKERS [J].
DIANZANI, F ;
CAPOBIANCHI, MR ;
FACCHINI, J .
JOURNAL OF VIROLOGY, 1984, 50 (03) :964-965
[5]   INVESTIGATION OF CYTOMEGALOVIRUS-INFECTION AS A RISK FACTOR FOR CORONARY ATHEROSCLEROSIS IN THE EXPLANTED HEARTS OF PATIENTS UNDERGOING HEART-TRANSPLANTATION [J].
DUMMER, S ;
LEE, A ;
BREINIG, MK ;
KORMOS, R ;
HO, MT ;
GRIFFITH, B .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (03) :305-309
[6]   The role of infection in restenosis and atherosclerosis: Focus on cytomegalovirus [J].
Epstein, SE ;
Speir, E ;
Zhou, YF ;
Guetta, E ;
Leon, M ;
Finkel, T .
LANCET, 1996, 348 :S13-S17
[7]   EFFECTS OF CYTOMEGALOVIRUS-INFECTION ON GROWTH-FACTOR PRODUCTION IN ENDOTHELIAL-CELLS AND FIBROBLASTS [J].
GARRETT, JS ;
NARUS, JC ;
BOHNSACK, JF ;
CARLING, DE ;
GRIEVES, KG ;
WALDMAN, WJ ;
SHADDY, RE .
PEDIATRIC RESEARCH, 1995, 38 (06) :1003-1008
[8]   QUANTITATION OF HUMAN CYTOMEGALOVIRUS DNA IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
GERNA, G ;
FURIONE, M ;
BALDANTI, F ;
PERCIVALLE, E ;
COMOLI, P ;
LOCATELLI, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (03) :674-683
[9]  
GUETTA E, 1995, CIRCULATION S, V92, P1
[10]  
HENDRIX MGR, 1990, AM J PATHOL, V136, P23